Trials / Completed
CompletedNCT02820311
Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Thorough QT Study to Evaluate the Effect of a Single Dose of TD-4208 on Cardiac Repolarization in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate if TD-4208, an investigational drug being developed to treat people with chronic obstructive pulmonary disease (COPD), has any effect on the electrical activity of the heart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-4208 175 mcg | via nebulizer |
| DRUG | TD-4208 700 mcg | via nebulizer |
| DRUG | Placebo for TD-4208 | via nebulizer |
| DRUG | Moxifloxacin 400 mg | oral |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-06-30
- Last updated
- 2022-02-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02820311. Inclusion in this directory is not an endorsement.